STOCK TITAN
  1. Home
  2. Sec-filings
  3. OMER
  4. [Form 4] OMEROS CORP Insider Trading Activity

Omeros Corp (OMER) VP Borges exercises options, sells stock in Jan 2026

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Omeros Corp executive David J. Borges, VP, Finance & CAO, reported option exercises and share sales in January 2026. On January 12, 2026, he sold 30,000 shares of common stock at a weighted average price of $12.72, leaving no common shares directly owned after that sale.

On January 13, 2026, Borges exercised a stock option for 30,000 shares at an exercise price of $3.06 per share and acquired those shares, then sold 30,000 shares the same day at a weighted average price of $12.3105, again ending with 0 common shares directly held. He continues to hold 65,000 stock options following these transactions.

The option referenced vests in 48 equal monthly installments starting on April 1, 2024. The filing notes that Borges has completed all currently planned sales of Omeros common stock.

Positive

  • None.

Negative

  • None.
Insider Borges David J.
Role VP, Finance & CAO
Sold 60,000 shs ($751K)
Type Security Shares Price Value
Exercise Stock Option (right to buy) 30,000 $0.00 --
Exercise Common stock 30,000 $3.06 $92K
Sale Common stock 30,000 $12.3105 $369K
Sale Common stock 30,000 $12.72 $382K
Holdings After Transaction: Stock Option (right to buy) — 65,000 shares (Direct); Common stock — 30,000 shares (Direct)
Footnotes (1)
  1. This transaction was executed in multiple trades at prices ranging from $12.56 to $13.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. This transaction was executed in multiple trades at prices ranging from $12.13 to $12.62. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2024. Installments vest and become exercisable on each monthly anniversary thereafter.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Borges David J.
(Last) (First) (Middle)
201 ELLIOTT AVENUE WEST
(Street)
SEATTLE WA 98119
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OMEROS CORP [ OMER ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Finance & CAO
3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 01/12/2026 S 30,000 D $12.72(1) 0 D
Common stock 01/13/2026 M 30,000 A $3.06 30,000 D
Common stock 01/13/2026 S 30,000 D $12.3105(2) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $3.06 01/13/2026 M 30,000 (3) 04/25/2034 Common Stock 30,000 $0 65,000 D
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $12.56 to $13.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
2. This transaction was executed in multiple trades at prices ranging from $12.13 to $12.62. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
3. This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2024. Installments vest and become exercisable on each monthly anniversary thereafter.
Remarks:
The reporting person has completed all currently planned sales of Omeros Corporation's common stock.
/s/ Peter B. Cancelmo, Attorney-in-Fact 01/14/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did OMER VP David J. Borges report?

David J. Borges, VP, Finance & CAO of Omeros Corp (OMER), reported exercising a stock option for 30,000 shares of common stock on January 13, 2026 and selling common shares on January 12 and 13, 2026.

How many OMER shares did David J. Borges sell and at what prices?

Borges sold 30,000 shares of Omeros common stock on January 12, 2026 at a weighted average price of $12.72, and 30,000 shares on January 13, 2026 at a weighted average price of $12.3105, with each sale executed in multiple trades within stated price ranges.

What stock option did David J. Borges exercise in this Form 4 for OMER?

On January 13, 2026, Borges exercised a stock option (right to buy) covering 30,000 shares of Omeros common stock at an exercise price of $3.06 per share. The option has an expiration date of April 25, 2034.

How many Omeros securities does David J. Borges hold after these transactions?

Following the reported transactions, Borges directly holds 0 shares of Omeros common stock and 65,000 stock options according to the Form 4.

What is the vesting schedule of David J. Borges’ OMER stock option?

The referenced stock option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2024. Installments vest on each monthly anniversary thereafter.

Did the Form 4 for OMER mention future planned sales by David J. Borges?

The remarks state that Borges has completed all currently planned sales of Omeros Corporation’s common stock.

Were David J. Borges’ OMER share sales single trades or multiple trades?

Each reported sale was executed in multiple trades. For the $12.72 weighted average sale, individual trades ranged from $12.56 to $13.06, and for the $12.3105 weighted average sale, trades ranged from $12.13 to $12.62.